BeStock  

Amphastar Pharmaceuticals AMPH

$28.25 +$0.14 (+0.50%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.26 +0.04%
Open$28.14
Prev close$28.11
Day range$27.79 – $28.70
Volume498.5K
Market cap$1.20B
P/E (TTM)13.0
Dividend yield–

AMPH Stock News

Headlines matching Amphastar Pharmaceuticals or the AMPH ticker, most recent first.

  • Wells Fargo Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $20 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $20Market news · 7 Aug 2026 · Direct mention
  • Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20 NegativeMarket news · 7 Aug 2026 · Direct mention
  • Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $23 PositiveMarket news · 19 Aug 2026 · Direct mention
  • Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold RatingMarket news · 9 Jul 2026 · Direct mention
  • Amphastar Pharmaceuticals (AMPH) Gets a Hold From J.P. MorganTipRanks · 23 Jul 2026 · Direct mention
  • Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20 NegativeMarket news · 4 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Ardent Health Partners, Inc. (ARDT) and Amphastar Pharmaceuticals (AMPH)TipRanks · 3 Jun 2026 · Direct mention
  • BofA Securities Downgrades Amphastar Pharmaceuticals(AMPH.US) to Sell Rating, Cuts Target Price to $20 NegativeMarket news · 29 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI), Amphastar Pharmaceuticals (AMPH) and Amylyx Pharmaceuticals Inc (AMLX)TipRanks · 8 May 2026 · Direct mention
  • Needham Downgrades Amphastar Pharmaceuticals(AMPH.US) to Hold Rating NegativeMarket news · 8 May 2026 · Direct mention
  • Wells Fargo Initiates Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $19Market news · 14 May 2026 · Direct mention
  • Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $21 NegativeMarket news · 11 May 2026 · Direct mention
  • Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $23 NegativeMarket news · 8 Apr 2026 · Direct mention
  • Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $30Market news · 15 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AMPH.

Sign in to join the discussion.

Scroll to Top